Chronic Hyperkalemia Management and Outcomes in CKD: Update

Chronic Hyperkalemia Management and Outcomes in CKD: Update is organized by National Kidney Foundation (NKF).

Course Opens: 06/28/2019
Course Expires: 06/28/2020

Target Audience: 
• Physicians 
• Pharmacists
• Physician Assistants 
• Nurse Practitioners
• Nurses  
• Dietitians 
• Social Workers

Available Credit:
• 0.67 AANP and ANCC Pharmacology
• 1.50 ACPE Contact Hours
• 1.50 AMA PRA Category 1 Credit™
• 1.50 ANCC Nurse Contact Hours
• 1.50 ASWB Continuing Education Clock Hours
• 0.67 ANCC Pharmacology
• 1.50 Attendance
• 1.50 Category I Credit for Physician Assistants
• 1.50 CDR CPEUs

Description:
Hyperkalemia is one of the most common electrolyte abnormalities in patients with advanced stage CKD and ESRD. Due to its potential to induce malignant arrhythmias, severe hyperkalemia requires immediate intervention. This program will share updates on the most recent advances relevant to the role of decreased kidney function and ancillary comorbid conditions in the development of hyperkalemia, the association of hyperkalemia with adverse outcomes, and the currently available treatment regimens for acute and chronic hyperkalemia management and their potential impact on outcomes such as quality control measures and patient satisfaction.

Learning Objectives:
After participation in this activity, learners will be better able to:
• Review the physiology of potassium homeostasis and the pathophysiology and epidemiology of hyperkalemia
• Describe the interventions available for the treatment of acute and chronic hyperkalemia and their potential impact on patient outcomes and measures of quality of care
• Examine the comparative efficacy and safety of potassium binders available for the treatment of hyperkalemia and their potential impact on patient outcomes and measures of quality of care

Additional details will be posted as soon as they are available.